Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder typically treated first-line with stimulants. This review provides guidance to prescribers by presenting an overview of available treatment options, along with clinical and real-world evidence for delayed-release and extended-release methylphenidate (DR/ER-MPH). Traditional long-acting stimulants differ in duration of effect, leading to gaps in symptom control during the afternoon and evening. DR/ER-MPH is a unique…
